January 2015 FDA Recall Drug by Sca Pharmaceuticals
D-0339-2015 - Labeling
This Class II drug recall was voluntarily initiated by Sca Pharmaceuticals on January 2, 2015 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed in Louisiana and the recall is currently terminated.
Recall Number: D-0339-2015
Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".
01-02-2015
01-21-2015
972 syringes
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
SCA Pharmaceuticals
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Louisiana
04-22-2015
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, 877-550-5059
Batch or Lot Expiration Information
Lot# : 20141218@41, Use by 3/18/2015; 20141226@24, Use by 3/26/2015